Region: Global
Category: Life Sciences

Global Life Sciences

(45,027 reports matching your criteria)
  • Biotechnology

    ... 8.5% over the analysis period 2024-2030. DNA Sequencing Technology, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$33.5 Billion by the end of the analysis period. ... Read More

  • Blood Transfusion Diagnostics

    ... at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the ... Read More

  • Breast Surgery Retractors

    ... at a CAGR of 2.5% over the analysis period 2024-2030. Single-Arm Retractors, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$497.8 Million by the end of ... Read More

  • Diabetic Shoes

    ... CAGR of 8.1% over the analysis period 2024-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$10.6 Billion by the end of the ... Read More

  • Endometrial Ablation Devices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More

  • Facial Injectables

    ... CAGR of 6.9% over the analysis period 2024-2030. Botulinum Toxin Type A, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$16.0 Billion by the end of ... Read More

  • Fragment-based Drug Discovery

    ... at a CAGR of 8.8% over the analysis period 2024-2030. Fragment Screening Technology, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$1.1 Billion by the end ... Read More

  • Healthcare Information Systems

    ... at a CAGR of 11.4% over the analysis period 2024-2030. Web-based Deployment, one of the segments analyzed in the report, is expected to record a 10.5% CAGR and reach US$396.5 Billion by the end of ... Read More

  • Hospital Linen Supply and Management Services

    ... reach US$11.7 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Bed Sheet & Pillow Covers, one of the segments analyzed in the report, is expected to record a 3.5% ... Read More

  • LED Video Walls

    ... at a CAGR of 6.9% over the analysis period 2024-2030. Indoor Deployment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.0 Billion by the end of ... Read More

  • Nail Care

    ... CAGR of 2.6% over the analysis period 2024-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$8.3 Billion by the end of the analysis ... Read More

  • Non-Surgical Skin Tightening Devices

    ... 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Laser Based Devices, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$391.1 Million by ... Read More

  • Transcatheter Embolization and Occlusion Devices

    ... Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Embolization Coils, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.8 Billion ... Read More

  • Vitreous Tamponades

    ... CAGR of 3.0% over the analysis period 2024-2030. Gaseous Tamponades, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$50.9 Million by the end of the analysis ... Read More

  • Fibrin Sealants

    ... CAGR of 6.1% over the analysis period 2024-2030. Fibrin Sealant Liquid, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.2 Billion by the end of the ... Read More

  • Sodium Bromide

    ... CAGR of 6.2% over the analysis period 2024-2030. Powdered Sodium Bromide, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.7 Billion by the end of the ... Read More

  • Rapid Antigen Detection Tests

    ... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$88.4 Million While China is Forecast to Grow at 12.4% CAGR The Rapid Antigen Detection Tests market ... Read More

  • Neurology Devices

    ... CAGR of 5.9% over the analysis period 2024-2030. Cerebrospinal Fluid Management, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.1 Billion by the end of the ... Read More

  • Veterinary Services

    ... CAGR of 3.4% over the analysis period 2024-2030. Production Animal, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$77.9 Billion by the end of the analysis ... Read More

  • Biological Drugs

    ... CAGR of 9.1% over the analysis period 2024-2030. Therapeutic Protein, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$289.1 Billion by the end of the analysis ... Read More

  • Biologics

    ... 8.2% over the analysis period 2024-2030. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$271.3 Billion by the end of the analysis period. ... Read More

  • Biopharmaceutical Logistics

    ... CAGR of 4.8% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$37.9 Billion by the end of the ... Read More

  • Biomedical Refrigerators and Freezers

    ... 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Ultra Low Temperature (ULT) Freezers, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$533.2 ... Read More

  • Diagnostic Specialty Enzymes

    ... at a CAGR of 6.2% over the analysis period 2024-2030. Polymerases & Nucleases, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$726.2 Million by the end ... Read More

  • Endoscopic Ultrasound Needles

    ... at a CAGR of 2.7% over the analysis period 2024-2030. Aspiration Needles (EUS-FNA), one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$150.5 Million by the end ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings